|
breast cancer |
9 |
|
gastric cancer |
8 |
|
humans |
8 |
|
nicotine |
8 |
|
animals |
7 |
|
cell proliferation - drug effects |
7 |
|
colon cancer |
7 |
|
cox-2 |
7 |
|
male |
7 |
|
medical sciences |
7 |
|
microrna |
7 |
|
pten |
7 |
|
biomarkers |
6 |
|
cell line, tumor |
6 |
|
cell proliferation |
6 |
|
cigarette smoke |
6 |
|
pediatric cardiology |
6 |
|
rats |
6 |
|
rats, sprague-dawley |
6 |
|
receptors, adrenergic, beta - drug effects - metabolism |
6 |
|
signal transduction - drug effects |
6 |
|
ventricular function |
6 |
|
β-adrenergic receptor |
6 |
|
angiogenesis |
5 |
|
apoptosis |
5 |
|
breast cancer risk |
5 |
|
c-myc |
5 |
|
chinese |
5 |
|
cigarette smoking |
5 |
|
cyclooxygenase-2 |
5 |
|
dose-response relationship, drug |
5 |
|
emt |
5 |
|
gastric ulcer |
5 |
|
hereditary breast cancer |
5 |
|
mucus |
5 |
|
nicotine - pharmacology |
5 |
|
nnk |
5 |
|
ornithine decarboxylase |
5 |
|
palb2 mutation |
5 |
|
stress |
5 |
|
wound healing - drug effects |
5 |
|
5-lox |
4 |
|
adenocarcinoma - metabolism - physiopathology |
4 |
|
adrenaline |
4 |
|
adrenergic beta-antagonists - pharmacology |
4 |
|
apoptosis - drug effects |
4 |
|
atenolol - pharmacology |
4 |
|
biomarker |
4 |
|
brca-negative |
4 |
|
breast neoplasms - blood - diagnosis - genetics - pathology |
4 |
|
butadienes - pharmacology |
4 |
|
carcinogens - toxicity |
4 |
|
cell division - drug effects |
4 |
|
circulating microrna |
4 |
|
colorectal neoplasms |
4 |
|
crc patients |
4 |
|
cyclooxygenase 2 - biosynthesis |
4 |
|
diagnostic marker |
4 |
|
dinoprostone - metabolism |
4 |
|
dna methylation - genetics |
4 |
|
down-regulation - genetics |
4 |
|
enzyme induction - drug effects |
4 |
|
ep4 |
4 |
|
extracellular signal-regulated map kinases - metabolism |
4 |
|
hypermethylation |
4 |
|
killin |
4 |
|
membrane proteins - biosynthesis |
4 |
|
membrane transport proteins - genetics |
4 |
|
methylation |
4 |
|
micrornas - physiology |
4 |
|
mir-92 |
4 |
|
mitogens - pharmacology |
4 |
|
multigene panel |
4 |
|
myeloperoxidase |
4 |
|
nf-kappa b - physiology |
4 |
|
nf-κb |
4 |
|
nitriles - pharmacology |
4 |
|
nitrosamines - toxicity |
4 |
|
notch1 |
4 |
|
ovarian cancer |
4 |
|
phosphorylation - drug effects |
4 |
|
proliferation |
4 |
|
propanolamines - pharmacology |
4 |
|
prostaglandin e2 |
4 |
|
protein kinase c |
4 |
|
protein kinase c - metabolism |
4 |
|
protein kinase inhibitors - pharmacology |
4 |
|
protein transport - drug effects |
4 |
|
proto-oncogene proteins c-bcl-2 - metabolism |
4 |
|
receptors, prostaglandin e, ep2 subtype - physiology |
4 |
|
receptors, prostaglandin e, ep4 subtype - physiology |
4 |
|
smoking - adverse effects |
4 |
|
somatic mutations |
4 |
|
staurosporine - pharmacology |
4 |
|
stomach neoplasms - blood - diagnosis - genetics - pathology |
4 |
|
stomach neoplasms - metabolism - physiopathology |
4 |
|
stomach neoplasms - pathology |
4 |
|
thyroid cancer |
4 |
|
transcription factor ap-1 - biosynthesis |
4 |
|
adenocarcinoma - metabolism |
3 |
|
adenoma - etiology - pathology |
3 |
|
analgesics, opioid - pharmacology |
3 |
|
angelica sinensis |
3 |
|
arachidonate 5-lipoxygenase - metabolism |
3 |
|
b-cell lymphoma 2 |
3 |
|
blood vessels - drug effects |
3 |
|
blotting, western |
3 |
|
brca |
3 |
|
bungarotoxins - pharmacology |
3 |
|
cell apoptosis |
3 |
|
cell transformation, neoplastic |
3 |
|
chronic disease |
3 |
|
circulating cell-free mirna |
3 |
|
cold temperature |
3 |
|
colitis, ulcerative - etiology - pathology |
3 |
|
colonic neoplasms - etiology - pathology |
3 |
|
compound heterozygous mutations |
3 |
|
cyclin d1 - metabolism |
3 |
|
cyclooxygenase |
3 |
|
cyclooxygenase 2 - drug effects - metabolism |
3 |
|
dextran sulfate - toxicity |
3 |
|
dnmt3a |
3 |
|
e-cadherin |
3 |
|
endothelial growth factors - metabolism |
3 |
|
epidermal growth factor receptor |
3 |
|
epithelial cells - cytology |
3 |
|
fanconi anemia |
3 |
|
gastric epithelial cells |
3 |
|
gastric mucosa - blood supply - drug effects - pathology |
3 |
|
gene expression regulation - drug effects |
3 |
|
hereditary breast and ovarian cancers |
3 |
|
intercellular signaling peptides and proteins - metabolism |
3 |
|
lactobacillus rhamnosus |
3 |
|
large genmic rearrangements |
3 |
|
lymphokines - metabolism |
3 |
|
mesoderm - cytology |
3 |
|
mice |
3 |
|
mice, inbred balb c |
3 |
|
mir-143 |
3 |
|
mir-199a-5p |
3 |
|
morphine |
3 |
|
morphine - pharmacology |
3 |
|
multiplex ligation-dependent probe amplification |
3 |
|
naloxone - pharmacology |
3 |
|
neovascularization, pathologic - etiology |
3 |
|
neovascularization, physiologic - drug effects |
3 |
|
nicotine - toxicity |
3 |
|
nicotinic acetylcholine receptor |
3 |
|
obstetrics and gynecology |
3 |
|
ornithine decarboxylase - biosynthesis |
3 |
|
p38 mitogen-activated protein kinases - drug effects - metabolism |
3 |
|
phosphorylation |
3 |
|
probiotics - therapeutic use |
3 |
|
propranolol - pharmacology |
3 |
|
proto-oncogene proteins c-bcl-2 - analysis |
3 |
|
receptor, epidermal growth factor - metabolism |
3 |
|
receptors, nicotinic - drug effects - metabolism |
3 |
|
receptors, prostaglandin e, ep2 subtype - metabolism |
3 |
|
receptors, prostaglandin e, ep4 subtype - metabolism |
3 |
|
smoke - adverse effects |
3 |
|
snail |
3 |
|
stomach - drug effects - pathology |
3 |
|
stomach - microbiology |
3 |
|
stomach neoplasms - chemically induced - metabolism |
3 |
|
stomach neoplasms - enzymology - pathology |
3 |
|
stomach neoplasms - metabolism |
3 |
|
stomach ulcer - drug therapy |
3 |
|
stomach ulcer - etiology - prevention & control |
3 |
|
stress, physiological - complications |
3 |
|
time factors |
3 |
|
tp53 mutation |
3 |
|
triple-negative breast cancer |
3 |
|
tumor cells, cultured |
3 |
|
tumor suppressor |
3 |
|
vascular endothelial growth factor a |
3 |
|
vascular endothelial growth factor a - analysis |
3 |
|
vascular endothelial growth factors |
3 |
|
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (nnk) |
2 |
|
acetylcholine receptors |
2 |
|
adenocarcinoma |
2 |
|
adenocarcinoma - enzymology - etiology - prevention & control |
2 |
|
adenocarcinoma - etiology - metabolism - psychology |
2 |
|
adenoma - etiology - prevention & control |
2 |
|
adolescent |
2 |
|
adrenergic receptors |
2 |
|
adult |
2 |
|
aged |
2 |
|
arachidonate 5-lipoxygenase - genetics - metabolism |
2 |
|
b-cell lymphoma-2 |
2 |
|
bcl-2 |
2 |
|
blood flow |
2 |
|
brca1 |
2 |
|
brca1/2 |
2 |
|
brca2 |
2 |
|
breast and ovarian cancer |
2 |
|
breast neoplasms |
2 |
|
breast-cancer |
2 |
|
cancer cells |
2 |
|
cancer development |
2 |
|
case-control studies |
2 |
|
caspase 3 |
2 |
|
caspase-3 inhibitor |
2 |
|
caspases - metabolism |
2 |
|
cathelicidin antimicrobia |
2 |
|
cell division |
2 |
|
cell migration |
2 |
|
cell movement |
2 |
|
chinese population |
2 |
|
chromosome 5 |
2 |
|
cigarette smoke extracts |
2 |
|
cilengitide |
2 |
|
clinical application |
2 |
|
colitis |
2 |
|
colitis, ulcerative - complications |
2 |
|
colonic neoplasms - enzymology - etiology - prevention & control |
2 |
|
colonic neoplasms - etiology - metabolism - psychology |
2 |
|
colonic neoplasms - etiology - prevention & control |
2 |
|
colorectal neoplasms - diagnosis - genetics |
2 |
|
communicable diseases |
2 |
|
complementary dna |
2 |
|
crohn's disease |
2 |
|
cyclooxygenase 2 |
2 |
|
cyclooxygenase 2 - physiology |
2 |
|
cyclooxygenase 2 inhibitors |
2 |
|
cyclooxygenase inhibitors - therapeutic use |
2 |
|
cytochrome c |
2 |
|
cytochrome c group - metabolism |
2 |
|
dextran sulfate |
2 |
|
diagnosis |
2 |
|
dna fragmentation |
2 |
|
dna methylation |
2 |
|
duodenal ulcer - drug therapy - metabolism |
2 |
|
early detection of cancer |
2 |
|
enzyme-linked immunosorbent assay |
2 |
|
epidermal growth factor - isolation & purification - metabolism |
2 |
|
epithelial cells - drug effects - enzymology - pathology |
2 |
|
ezrin |
2 |
|
female |
2 |
|
flow cytometry |
2 |
|
gastric mucosa - drug effects - enzymology - pathology |
2 |
|
gastric mucosa - drug effects - metabolism |
2 |
|
gastric mucosa - metabolism - pathology |
2 |
|
gastric ulcer healing |
2 |
|
gastric ulceration |
2 |
|
gastritis - drug therapy - metabolism |
2 |
|
gastroenterology |
2 |
|
gene |
2 |
|
gene expression regulation, neoplastic - genetics |
2 |
|
genes section |
2 |
|
genetic testing |
2 |
|
germline mutations |
2 |
|
glutathione |
2 |
|
glycolysis |
2 |
|
gpi |
2 |
|
haptoglobin |
2 |
|
helicobacter infections - drug therapy - metabolism |
2 |
|
helicobacter pylori |
2 |
|
heparin |
2 |
|
itgav |
2 |
|
k+ channel |
2 |
|
l-lactate dehydrogenase - metabolism |
2 |
|
leukotriene b4 - metabolism |
2 |
|
lipoxygenase inhibitors - therapeutic use |
2 |
|
messenger-rna decay |
2 |
|
metastasis |
2 |
|
mice, nude |
2 |
|
micro rna |
2 |
|
micrornas - genetics - metabolism |
2 |
|
middle aged |
2 |
|
mir-204 |
2 |
|
mirn143 (alias) |
2 |
|
mirna |
2 |
|
muscarinic receptors |
2 |
|
mutation |
2 |
|
nachrs |
2 |
|
neoplastic cells, circulating - metabolism |
2 |
|
neovascularization, pathologic - prevention & control |
2 |
|
nicotine - physiological effect. |
2 |
|
nicotine receptor |
2 |
|
nicotinic receptors |
2 |
|
odc |
2 |
|
ovarian |
2 |
|
penetrance |
2 |
|
peptic ulcer. |
2 |
|
phyllodes tumuor of breast |
2 |
|
polyamines - metabolism |
2 |
|
polymerase chain reaction |
2 |
|
polysaccharide |
2 |
|
polysaccharides |
2 |
|
prognosis |
2 |
|
prostaglandin-endoperoxide synthases - drug effects - genetics - metabolism |
2 |
|
pyrazoles - therapeutic use |
2 |
|
ras |
2 |
|
receptor, epidermal growth factor - isolation & purification - metabolism |
2 |
|
recql mutation |
2 |
|
restraint stress |
2 |
|
retinoblastoma |
2 |
|
risk factor |
2 |
|
rna, messenger - metabolism |
2 |
|
smoking |
2 |
|
smoking - adverse effects - metabolism - physiopathology |
2 |
|
stomach - cancer - etiology. |
2 |
|
stomach - ulcers. |
2 |
|
stomach neoplasms |
2 |
|
stomach ulcer - etiology - metabolism - physiopathology |
2 |
|
stress, psychological - complications |
2 |
|
sulfonamides - therapeutic use |
2 |
|
tobacco |
2 |
|
tobacco - adverse effects - chemistry |
2 |
|
tobacco - physiological effect. |
2 |
|
triple negative breast cancer (tnbc) |
2 |
|
tumor associated macrophage |
2 |
|
tumor markers, biological - genetics - metabolism |
2 |
|
tumor microenvironment |
2 |
|
tumor-suppressor |
2 |
|
ulcerative colitis |
2 |
|
wound healing |
2 |
|
wound healing. |
2 |
|
5-lipoxygenase |
1 |
|
animal models |
1 |
|
anticoagulants - blood - pharmacology |
1 |
|
bfgf (basic fibroblast growth factor) |
1 |
|
cancer |
1 |
|
cell transformation, neoplastic - genetics - metabolism |
1 |
|
colorectal cancer |
1 |
|
cyclooxygenase-2 (cox-2) |
1 |
|
cyclophosphamide |
1 |
|
dexamethasone |
1 |
|
dextran sulfate sodium |
1 |
|
dtwd1 |
1 |
|
epigenesis, genetic |
1 |
|
extracellular signal-regulated kinase (erk) |
1 |
|
fructose-bisphosphatase - genetics - metabolism |
1 |
|
gastrointestinal diseases |
1 |
|
gastrointestinal tract |
1 |
|
gls1 |
1 |
|
glucose metabolism |
1 |
|
glutamine metabolism |
1 |
|
golph3 |
1 |
|
hdac |
1 |
|
heme oxygenase |
1 |
|
heparin, low-molecular-weight - blood - chemistry - pharmacology |
1 |
|
hsf1 |
1 |
|
inflammation |
1 |
|
leukopenia |
1 |
|
mir137hg |
1 |
|
mmp |
1 |
|
non-small-cell lung cancer |
1 |
|
ornithine decarboxylase (odc) |
1 |
|
p53 |
1 |
|
phospholipase a 2 |
1 |
|
prostaglandin e 2 |
1 |
|
stomach neoplasms - genetics - metabolism - pathology |
1 |
|
stomach ulcer - chemically induced - drug therapy - physiopathology |
1 |
|
tissue injury |
1 |
|
tumor suppressor gene |
1 |
|
vegf (vascular endothelial growth factor) |
1 |
|
vegf1 |
1 |
